Ex-Pfizer SVP named CEO of BioClinica

BioClinica has named John Hubbard as its new CEO. Hubbard joins the company from Pfizer ($PFE), where he worked as senior vice president and worldwide head of development operations. The move sees Hubbard step back into the vendor and service provider sector, a field with which he is familiar. Prior to joining Pfizer, Hubbard headed up clinical research services at Icon ($ICLR). Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.